9 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ARRY Array BioPharma Inc. $13.73 $2.91B N/A
Article Searches
Your Cancer Highlight: Loxo Breaks Through Again, Now With Its Own Drug https://seekingalpha.com/article/4204799-cancer-highlight-loxo-breaks-now-drug?source=feed_sector_healthcare Sep 07, 2018 - Loxo is an important success story of our time, making big gains for investors and the oncology community alike.More breakthroughs give the company an important in to continue its growth.With a ceilin
Stocks To Watch: Tech Earnings Bellwethers Set To Test Rally https://seekingalpha.com/article/4212924-stocks-watch-tech-earnings-bellwethers-set-test-rally?source=feed Oct 20, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Array BioPharma Inc. 2019 Q1 - Results - Earnings Call Slides https://seekingalpha.com/article/4215791-array-biopharma-inc-2019-q1-results-earnings-call-slides?source=feed_all_articles Oct 30, 2018 -
Story Stocks: Commscope: Will ARRIS deal jump-start a turnaround for communications giant? (COMM) http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=NS20181108103638StoryStocks Nov 08, 2018 - Communications company Commscope (COMM 19.95, -4.54, -18.5%) announced this morning the acquisition
Array BioPharma (ARRY) Reports Q1 Loss, Tops Revenue Estimates http://www.zacks.com/stock/news/332687/array-biopharma-arry-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-332687 Oct 30, 2018 - Array BioPharma (ARRY) delivered earnings and revenue surprises of 42.86% and 59.55%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Array BioPharma's (ARRY) CEO Ron Squarer on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4216046-array-biopharmas-arry-ceo-ron-squarer-q1-2019-results-earnings-call-transcript?source=feed_sector_transcripts Oct 30, 2018 - Array BioPharma Inc. (NASDAQ:ARRY) Q1 2019 Earnings Conference Call October 30, 2018 09:00 AM ET Executives Andrea Flynn – Senior Director-Investor Relations and Corporate Communications Ron Squarer –
CommScope, getting ready for 5G, spends $5.7B for Arris http://www.startribune.com/business/500025681.html Nov 08, 2018 -
Stocks To Watch: All Eyes On Walmart, Volkswagen And A Jedi Contract https://seekingalpha.com/article/4220754-stocks-watch-eyes-walmart-volkswagen-jedi-contract?source=feed Nov 10, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
All Eyes On Walmart, Volkswagen And A Jedi Contract (Stocks To Watch Podcast) https://seekingalpha.com/article/4221002-eyes-walmart-volkswagen-jedi-contract-stocks-watch-podcast?source=feed_all_articles Nov 11, 2018 - Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks

Pages: 1

Page 1

Related Companies

Name Exchange Price Mkt Cap
ASND Ascendis Pharma A/S NASDAQ $68.28 $2.87B
BPMC Blueprint Medicines Corporation NASDAQ $68.7 $3.02B
HRTX Heron Therapeutics, Inc. NASDAQ $33.8 $2.63B
IRWD Ironwood Pharmaceuticals, Inc. NASDAQ $17.1 $2.62B
HZNP Horizon Pharma plc NASDAQ $19.22 $3.2B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Array BioPharma